The biomarker human neutrophil lipocalin HNL was previously shown to be a useful indicator of bacterial infections. Now, the ...

Offering a simpler alternative to PET scans and CSF analysis, blood-based biomarker tests could improve accessibility of ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

Cofactor Genomics has showcased positive data highlighting that its clinical biomarker assay OncoPrism-HNSCC could guide ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

Compass Therapeutics (CMPX) announced its poster presentation entitled “Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of ...

The biomarker human neutrophil lipocalin HNL, which was previously shown to be a useful indicator of bacterial infections, may also in the form of Dimeric HNL be used to effectively monitor the ...

Purple Biotech (PPBT) has released an update. Purple Biotech has identified a new serum biomarker, CEACAM1, which may ...

Results of a study recently published in the journal JCO Precision Oncology show that in the clinical trial context, combined ...

Researchers from Nanjing University and the Army Engineering University of PLA have published a review in ExRNA, shedding ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

While early detection of Alzheimer’s disease is crucial for better outcomes, a report on Wednesday said that blood-based ...